Clinical outcomes of mother to child transmission and diagnostic difficulties 
Clinical outcomes of mother to child transmission and diagnostic difficulties . These rates compare with rates of MTCT in maternal cytomegalovirus (CMV) infection of 32% in primary infection and 1.4% during reactivation 5 , and for rubella of 80% to 25%, depending upon gestation 6 . Effects on the fetus for all these infections depend upon many factors, including maternal immunity, gestation of infection, and viral characteristics.
Identification of mothers infected with ZIKV is predominantly via symptoms, serology, and molecular testing of the acutely infected person. Diagnosis is confounded by the low rate of symptoms (in~20% of adults), technical difficulties with serology crossreactivity, and the brief period of viraemia in some infections.
Serology diagnostic problems occur due to co-circulation of other flaviviruses (particularly Dengue virus) in ZIKV affected areas.
Cross-reactivity between ZIKV and Dengue virus occurs 
Placental and fetal infection
Most microcephaly is thought to arise from first trimester (T1) infection, although sampling difficulties occur with the high rate of asymptomatic infection. ZIKV has been detected in fetal brain tissue from microcephalic infants, in amniotic fluid taken from mothers of affected infants 13 , and from central nervous system tissue of affected microcephalic infants 14 . These are mainly observational data with minimal controls, albeit with autopsy and ultrasound data being consistent with microcephaly resulting from ZIKV infection during pregnancy 15 . ZIKV has been known to be neurotropic in animals for 60 years, with more recent murine experiments demonstrating replication in embryonic brain targeting neural progenitor cells, with consequent cell cycle arrest, apoptosis and inhibited neural progenitor cell differentiation 9, 16 . This is presumed to result in the microcephalic phenotype via neuronal cell death 16 . This is consistent with observations that African ZIKV strains infect neural precursor cells in murine models (summarised in Klase et al.
17
).
Mother to child transmission (MTCT) studies often use models from T2 or T3 placentae, which differ from T1 placentae in structure, cell components and surface markers. Studies of infection of explanted placentae in other viral infections such as with CMV show neonatal neural malformation and intra uterine death may be caused partly through Th1 cytokine-induced placental damage 18, 19 .
The placenta is a complex organ that changes significantly over pregnancy, and comprises some unique cells with differential 10, 18 , with the potential to significantly reduce the risk of congenital ZIKV abnormalities, as has occurred with the successful use of vaccines for rubella virus.
Finally, all sources of ZIKV transmission to pregnant women should be avoided, including via blood products, as these may be infected despite being from asymptomatic individuals 22 .
